Tyrosine Kinase Inhibitor Sunitinib Targets the Vasculature of Clear Cell Renal Cell Carcinoma: A Histological and Immunocytochemical Study of Treatment Effect

被引：0
|
作者：
Huang, J. [1 ]
Thomas, A. [1 ]
Simmerman, K. [1 ]
Sercia, L. [1 ]
Magi-Galluzzi, C. [1 ]
Campbell, S. [1 ]
Rini, B. [1 ]
Zhou, M. [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
来源：
LABORATORY INVESTIGATION | 2010年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
873
引用
收藏
页码：197A / 197A
页数：1
相关论文
共 50 条
  • [21] SPHINGOSINE KINASE 1 OVEREXPRESSION CONTRIBUTES TO SUNITINIB RESISTANCE IN CLEAR CELL RENAL CELL CARCINOMA
    Xu, Yunze
    Huang, Yiran
    JOURNAL OF UROLOGY, 2019, 201 (04): : E298 - E298
  • [22] Sphingosine kinase 1 overexpression contributes to sunitinib resistance in clear cell renal cell carcinoma
    Xu, Yunze
    Dong, Baijun
    Wang, Jianfeng
    Zhang, Jin
    Xue, Wei
    Huang, Yiran
    ONCOIMMUNOLOGY, 2018, 7 (12):
  • [23] Myxoid renal cell carcinoma: Histological, immunocytochemical and ultrastructural study
    Birch, HA
    Glass, JM
    Vale, J
    Walker, MM
    JOURNAL OF CLINICAL PATHOLOGY, 1996, 49 (12) : 1015 - 1017
  • [24] Tyrosine Kinase Inhibitor-Induced Vasculopathy in Clear Cell Renal Cell Carcinoma as an Anti-Tumor Mechanism
    Tsuzuki, T.
    Sassa, N.
    Morikawa, T.
    Fukatsu, A.
    Yoshino, Y.
    Hattori, R.
    Shiroki, R.
    Gotoh, M.
    LABORATORY INVESTIGATION, 2012, 92 : 246A - 246A
  • [25] Tyrosine Kinase Inhibitor-Induced Vasculopathy in Clear Cell Renal Cell Carcinoma as an Anti-Tumor Mechanism
    Tsuzuki, T.
    Sassa, N.
    Morikawa, T.
    Fukatsu, A.
    Yoshino, Y.
    Hattori, R.
    Shiroki, R.
    Gotoh, M.
    MODERN PATHOLOGY, 2012, 25 : 246A - 246A
  • [26] Complexity of Tumor Vasculature in Clear Cell Renal Cell Carcinoma
    Qian, Chao-Nan
    Huang, Dan
    Wondergem, Bill
    Teh, Bin Tean
    CANCER, 2009, 115 (10) : 2282 - 2289
  • [27] Hyponatremia as a powerful prognostic predictor for Japanese patients with clear cell renal cell carcinoma treated with a tyrosine kinase inhibitor
    Furukawa, Junya
    Miyake, Hideaki
    Kusuda, Yuji
    Fujisawa, Masato
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (02) : 351 - 357
  • [28] Hyponatremia as a powerful prognostic predictor for Japanese patients with clear cell renal cell carcinoma treated with a tyrosine kinase inhibitor
    Junya Furukawa
    Hideaki Miyake
    Yuji Kusuda
    Masato Fujisawa
    International Journal of Clinical Oncology, 2015, 20 : 351 - 357
  • [29] Tyrosine Kinase Inhibitor Sorafenib Decreases 111In-Girentuximab Uptake in Patients with Clear Cell Renal Cell Carcinoma
    Muselaers, Constantijn H. J.
    Stillebroer, Alexander B.
    Desar, Ingrid M. E.
    Boers-Sonderen, Marye J.
    van Herpen, Carla M. L.
    de Weijert, Mirjam C. A.
    Langenhuijsen, Johan F.
    Oosterwijk, Egbert
    Leenders, William P. J.
    Boerman, Otto C.
    Mulders, Peter F. A.
    Oyen, Wim J. G.
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (02) : 242 - 247
  • [30] Epithelial-mesenchymal transition as a mechanism of the acquired tyrosine kinase inhibitor resistance in clear cell renal cell carcinoma
    Hwang, Hee Sang
    Go, Heounjeong
    Park, Ja-Min
    Yoon, Sun Young
    Lee, Jae-Lyun
    Jeong, Se Un
    Cho, Yong Mee
    LABORATORY INVESTIGATION, 2018, 98 : 351 - 351
12345